Turn Therapeutics Inc. TTRX

Annual Quarterly

No annual revenue total was found in Turn Therapeutics Inc.'s SEC filings.

Turn Therapeutics Inc. (TTRX) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Jun 30, 2026 it held $9.9 million in cash and investments and $7.3 million in total debt.

Revenue
—
Net income
$-3.19M
Operating cash flow
$-2.56M
Free cash flow
—
EPS
$-0.12
Dividend per share
None
Shares outstanding
29.79M
Net cash
$2.63M
as of Jun 30, 2026
Operating margin
—

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TTRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westlake Village, CA
SEC filer status
, Emerging growth company
SEC CIK
2023016
Former names
Global Health Solutions, Inc (until Sep 30, 2025)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2025
Dec 31, 2025
Operating income
-$5.9M
Net income
-$3.2M
Diluted EPS
-$0.12
Operating cash flow
-$2.6M
Total assets
$12.2M
Total liabilities
$7.5M
Stockholders' equity
$4.7M
Cash and investments
$4.0M
Total debt
$80,376

Recent SEC filings

Form Description Filed Period
ARS Annual report to shareholders Oct 19, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure
 Oct 7, 2026 Oct 6, 2026
8-K Current report
Regulation FD disclosure
 Sep 10, 2026 Sep 10, 2026
8-K Current report
Regulation FD disclosure
 Sep 9, 2026 Sep 9, 2026
8-K Current report
Unregistered share sale
 Aug 18, 2026 Aug 13, 2026
8-K Current report
Regulation FD disclosure
 Aug 17, 2026 Aug 14, 2026

All 122 Turn Therapeutics Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.